Atea Pharmaceuticals, Inc. AVIR
4.46 USD +0.29 (+6.95%)
At closeNov 4, 2026, 4:00 PM EST
4.46 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
4.24 Day range 4.49
2.87 52-week range 6.45
- YTD
- +24.93%
- 1 year
- +38.94%
Financial health
Altman Z-Score
2.60 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 4
Valuation
P/E -1.8×
FY 2018 5y median -1.8× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.1×
FY 2018 5y median 0.6× FY 2025
P/FCF -2.2×
FY 2018 5y median -3.0× FY 2025
EV/EBITDA -1.2×
FY 2018 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -45.4%
FY 2018 5y median -33.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -57.5%
FY 2018 5y median -24.5% FY 2025
ROIC -63.0%
FY 2018 5y median -29.1% FY 2025
ROA -50.2%
FY 2018 5y median -22.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 6.3%
FY 2018 FY 2025
EPS (diluted) 3.0%
FY 2018 FY 2025
Free Cash Flow 2.6%
FY 2018 FY 2025
Financial Health
Current Ratio 7.8×
FY 2018 5y median 18.2× FY 2025
Quick Ratio 7.8×
FY 2018 5y median 18.2× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2018 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31